Model for End-Stage Liver Disease | |
---|---|
Medical diagnostics | |
Purpose | assess the severity of chronic liver disease |
- MELD Scores & Liver Transplant Where am I on the LIST? What is MELD?: MELD stands for Model of End Stage Liver disease. It is a number value that indicates the severity of your liver disease.
- Meld is extremely easy to install - just untar and run. You can simply make a symlink to the untarred executable. (Optionally 'make' to generate translations).
- If you are running Mac OS 10.8 and greater, you will need to install xquartz which provides the X Window system required for Meld. If you have Mac OS prior to 10.8 you can skip this step. Install Meld and its dependencies: sudo port install rarian sudo port install meld.
- MAutoPitch is a simple but great sounding automatic pitch correction plugin designed for vocals and other monophonic instruments. Besides making the audio more in-tune, MAutoPitch also provides creative features such as formant shift and stereo-expansion. It is quick, easy to use and free! Included in: MFreeFXBundle MTotalFXBundle MCompleteBundle.
Meld is a visual diff and merge tool. You can compare two or three files and edit them in place (diffs update dynamically). You can compare two or three folders. Free Open Source Mac.
The Model for End-Stage Liver Disease, or MELD, is a scoring system for assessing the severity of chronic liver disease. Office word for mac. It was initially developed to predict mortality within three months of surgery in patients who had undergone a transjugular intrahepatic portosystemic shunt (TIPS) procedure,[1] and was subsequently found to be useful in determining prognosis and prioritizing for receipt of a liver transplant.[2][3] This score is now used by the United Network for Organ Sharing (UNOS) and Eurotransplant for prioritizing allocation of liver transplants instead of the older Child-Pugh score.[3][4]
Determination[edit]
MELD uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. It is calculated according to the following formula:[3] Vinyl cutter for mac.
- MELD = 3.78×ln[serum bilirubin (mg/dL)] + 11.2×ln[INR] + 9.57×ln[serum creatinine (mg/dL)] + 6.43
MELD scores are reported as whole numbers, so the result of the equation above is rounded.
Meld Diff Tool
UNOS has made the following modifications to the score:[5]
- If the patient has been dialyzed twice within the last 7 days, then the value for serum creatinine used should be 4.0 mg/dL
- Any value less than one is given a value of 1 (i.e. if bilirubin is 0.8 a value of 1.0 is used) to prevent subtraction from any of the three factors, since the natural logarithm of a positive number below 1 (greater than 0 and less than 1) yields a negative value.
The etiology of liver disease was subsequently removed from the model because it posed difficulties such as how to categorize patients with multiple causes of liver disease. Modification of the MELD score by excluding etiology of liver disease did not significantly affect the model's accuracy in predicting three-month survival.
Patients with a diagnosis of liver cancer will be assigned a MELD score based on how advanced the cancer is.[citation needed]
Interpretation[edit]
In interpreting the MELD Score in hospitalized patients, the 3 month observed mortality (considering 3437 adult liver transplant candidates with chronic liver disease who were added tothe OPTN waiting list at 2A or 2B status between November, 1999, and December, 2001) is:[6]
- 40 or more — 71.3% observed mortality
- 30–39 — 52.6% observed mortality
- 20–29 — 19.6% observed mortality
- 10–19 — 6.0% observed mortality
- <9 — 1.9% observed mortality
Applications of MELD score:
- The best outcomes with TIPS occur among patients with a MELD score less than 14.
- Patients with MELD scores greater than 24 who are reasonable liver transplant candidates are probably best served by foregoing TIPS placement.
History[edit]
![Meld for mac download Meld for mac download](https://freesoft.ru/storage/images/74/739/73875/73875_normal.png)
MELD was originally developed at the Mayo Clinic by Dr. Patrick Kamath, and at that point was called the 'Mayo End-stage Liver Disease' score. It was derived in a series of patients undergoing TIPS procedures. The original version also included a variable based on the underlying etiology (cause) of the liver disease.[1] The score turned out to be predictive of prognosis in chronic liver disease in general, and–with some modifications–came to be applied as an objective tool in assigning need for a liver transplant. The etiology turned out to be relatively unimportant, and was also regarded as relatively subjective; it was therefore removed from the score.[3]
MELD-Plus, a new score resulted from a collaboration between Massachusetts General Hospital and IBM was introduced in 2017.[7]
Potential of alternative scores to extend life expectancy[edit]
United Network for Organ Sharing proposed that MELD-Na score (an extension of MELD) may better rank candidates based on their risk of pre-transplant mortality and is projected to save 50-60 lives total per year.[8] Furthermore, a study published in the New England Journal of Medicine in 2008, estimated that using MELD-Na instead of MELD would save 90 lives for the period from 2005 to 2006.[9] In his viewpoint published in June 2018, co-creator of MELD-Plus, Uri Kartoun, suggested that ' ..MELD-Plus, if incorporated into hospital systems, could save hundreds of patients every year in the United States alone.'[10] Word for mac downloads.
See also[edit]
References[edit]
- ^ abMalinchoc, Michael; Kamath, Patrick S; Gordon, Fredric D; Peine, Craig J; Rank, Jeffrey; Ter Borg, Pieter C.J (2000). 'A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts'. Hepatology. 31 (4): 864–71. doi:10.1053/he.2000.5852. PMID10733541.
- ^Kamath, P; Wiesner, R. H; Malinchoc, M; Kremers, W; Therneau, T. M; Kosberg, C. L; d'Amico, G; Dickson, E. R; Kim, W. R (2001). 'A model to predict survival in patients with end-stage liver disease'. Hepatology. 33 (2): 464–70. doi:10.1053/jhep.2001.22172. PMID11172350.
- ^ abcdKamath, Patrick S; Kim, W. Ray (2007). 'The model for end-stage liver disease (MELD)'. Hepatology. 45 (3): 797–805. doi:10.1002/hep.21563. PMID17326206.
- ^Jung, G.E; Encke, J; Schmidt, J; Rahmel, A (2008). 'Model for end-stage liver disease'. Der Chirurg. 79 (2): 157–63. doi:10.1007/s00104-008-1463-4. PMID18214398.
- ^UNOS (2009-01-28). 'MELD/PELD calculator documentation'(PDF). Retrieved 2010-02-21.
- ^Wiesner, Russell; Edwards, Erick; Freeman, Richard; Harper, Ann; Kim, Ray; Kamath, Patrick; Kremers, Walter; Lake, John; Howard, Todd; Merion, Robert M; Wolfe, Robert A; Krom, Ruud; United Network for Organ Sharing Liver Disease Severity Score Committee (2003). 'Model for end-stage liver disease (MELD) and allocation of donor livers'. Gastroenterology. 124 (1): 91–6. doi:10.1053/gast.2003.50016. PMID12512033.
- ^Kartoun, Uri; Corey, Kathleen E; Simon, Tracey G; Zheng, Hui; Aggarwal, Rahul; Ng, Kenney; Shaw, Stanley Y (2017). 'The MELD-Plus: A generalizable prediction risk score in cirrhosis'. PLOS One. 12 (10): e0186301. doi:10.1371/journal.pone.0186301. PMC5656314. PMID29069090.
- ^https://optn.transplant.hrsa.gov/media/1834/liver_boardreport_20140702.pdf
- ^Kim, WR; Biggins, SW; Kremers, WK; Wiesner, RH; Kamath, PS; Benson, JT; Edwards, E; Therneau, TM (2008). 'Hyponatremia and mortality among patients on the liver-transplant waiting list'. N Engl J Med. 359 (10): 1018–6. doi:10.1056/NEJMoa0801209. PMC4374557. PMID18768945.
- ^Kartoun, Uri (2018). 'Toward an accelerated adoption ofmw-data:TemplateStyles:r886058088'>
External links[edit]
Library resources about Model for End-Stage Liver Disease |
Meld Diff For Mac
- Mobile friendly MELD score by MedWebApp
- Model for End-Stage Liver Disease Calculator by MDCalc
Retrieved from 'https://en.wikipedia.org/w/index.php?title=Model_for_End-Stage_Liver_Disease&oldid=885307945'
This README should help you build Meld for OS X. Splashtop for mac.
Preparing JHBuild Environment
JHBuild is the build system that we will be using to build Meld. This step should really be done once and further builds should not require updating the build environment unless there have been some updates to the libraries that you'd like to do.
Environment
To ensure that we don't hit some issue with python not able to determine locales on OSX, let's do the following
Initial Phase - JHBuild
- Install Command Line Tools
- Install brew if you don't have it
- Clean any previous
jhbuild
setup
- Ensure Python3 (required by new jhbuild) is used during the setup
Meld For Mac Mojave
- Install jhbuild
- Clone Meld and use our own custom jhbuildrc
Preparing Python3/GTK Environment
- Ensure that you have ccache
- Ensure that PATH is not tainted
- Build the environment
This is a very long process depending on your CPU and your Mac load. One an old Core i7 (late 2012), it's about two to three hours.
Building Meld
This isn't right yet. Work in progress.